FENC

Fennec Pharmaceuticals Inc.

Phase 1 AI-extracted

PEDMARK

metastatic germ cell tumor

Resolved

37days ago

Phase 1 readout · May 31, 2026

What's at stake Phase 1 trial results for PEDMARK in metastatic germ cell tumor are due May 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 15h ago

“Randomized Phase 1 Trial of Cisplatin-Based Chemotherapy With or Without Sodium Thiosulfate for Men with Metastatic Germ Cell Tumor (GCT) ... Date and Time : May 31, 2026”

Add to calendar Post on X Reddit

Provenance